Ulcerative colitis: Analyses of 116 cases (Do extraintestinal manifestations effect the time to catch remission?)

Hepato-Gastroenterology

Volumn 51, Issue 57, 2004, Pages 768-770

  Özdil, Sadakat ^a   Akyüz, Filiz ^a   Pinarbasi, Binnur ^a   Demir, Kadir ^a   Karaca, Cetin ^a   Boztas, Güngör ^a   Kaymakoglu, Sabahattin ^a   Mungan, Zeynel ^a   Besisik, Fatih ^a   Cakaloglu, Yilmaz ^a   Ökten, Atilla ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Extraintestinal manifestations; Treatment; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MESALAZINE; METHYLPREDNISOLONE;

ADULT; ANUS FISTULA; ARTHROPATHY; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL FEATURE; COLON PERFORATION; COLON RESECTION; CONTROLLED STUDY; DEMOGRAPHY; EVALUATION; FEMALE; GALLSTONE; HUMAN; ILEUM; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; RECTUM; REMISSION; SACROILIITIS; STEATOSIS; THROMBOSIS; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; FEMALE; HUMANS; MALE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 2342536417     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Rowe FA, Walker JH, Karp LC, et al: Factors predictive of response to cyclosporine treatment for severe, steroid-resistant ulcerative colitis. Am J Gastroenterol 2000; 95(8):2000-2008.
2. Vucelic B, Korac B, Sentic M, et al: Ulcerative colitis in Zagrep, Yugoslavia: A ten-year prospective study. Int J Epidemiol 1991; 20:216-220.
3. Rubin OP, Hungin APS, Kelly PJ, et al: Inflammatory bowel disease: Epidemiology and management in an English general practice population. Aliment Pharmacol Ther 2000; 14:1553-1559.
4. Loftus Jr EV, Silverstein MD, Sandborn WJ, et al: Ulcerative colitis in Olmsted country, Minnesota, 1940-1993: Incidence, prevalence and survival. Gut 2000; 46:336-343.
5. Farrell RJ, LaMont T: Microbial factors in inflammatory bowel disease. Gastroenterol Clin N Am 2002; 31:41-62.
6. Podolsky D: Inflammatory bowel disease: N Eng J Med 2002; 347(6):417-429.
7. Carucci LR, Levine MS: Radiologic imaging of inflammatory bowel disease. Gastroenterol Clin N Am 2002; 31:93-117.
8. Monsen U, Sorstad J, Hellers G et al: Extracolonic diagnosis in ulcerative colitis: An epidemiologic study. Am J Gastroenterol 1990; 85:711-716.
9. Jani N, Regueiro MD: Medical therapy for ulcerative colitis. Gastroenterol Clin N Am 2002; 31:147-166.
10. Seo M, Okada M, Yao T, et al: An index of disease activity in patients with ulcerative colitis: Am J Gastroenterol 1992; 87(8):971-976.
11. Bernstein C, Blanchard JF, Rawsthorne P: The prevalence of extraintestinal diseases in inflammatory bowel disease: Population-based study. Am J Gastroenterol 2001; 96(4):1117-1122.
12. Su CG, Judge TA, Lichtenstein GR: Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Clin N Am 2002; 32:307-327.
13. Sezer R, Mungan Z, Yalc□n S et al: Kolitis ulserozal? hastalarda karaciger biyopsi bulgular? Klinik gelisim 1990; 3:864-866.
14. Bargiggia S, Maconi O, Elli M, et al: Sonographic prevalence of liver steatosis and biliary tract stones in patients with inflammatory bowel disease: study of 511 subjects at a single center. J Clin Gastroenterol 2003; 36(5):417-420.
15. Santos J, Baudet S, Casellas F, et al: Efficacy of intravenous cyclosporine for steroid refractory attacks of ulcerative colitis. J Clin Gastroenterol 1995; 20:285-289.